Quest Diagnostics (NYSE:DGX) announced on Wednesday that it will roll out a rapid molecular lab test to detect the avian influenza A H5 virus. This initiative is part of an award from the U.S. Centers ...
Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, today announced the launch of a novel ...
WASHINGTON, CT, UNITED STATES, January 13, 2026 /EINPresswire.com/ -- Evexia Diagnostics, a leading provider of ...
Florida cuts ties with Quest Diagnostics after lab failed to report nearly 75K COVID-19 test results
TALLAHASSEE, Fla. — Following an order from Gov. Ron DeSantis, the Florida Department of Health and the Florida Department of Emergency Management are severing all ties with Quest Diagnostics after ...
NABL accreditation provides a strong foundation for the continued expansion of the company’s accredited test menu and ...
CLEVELAND--(BUSINESS WIRE)--Cleveland Diagnostics, Inc., a commercial-stage biotechnology company developing next-generation diagnostic tests for the early detection of cancers, has opened a new, ...
Please provide your email address to receive an email when new articles are posted on . The test, MelaNodal Predict, examines patient melanoma biopsies, and applies an algorithm to assess nodal ...
SECAUCUS, N.J. and HELSINKI, March 15, 2021 /PRNewswire/ -- Zora Biosciences Oy, a clinical diagnostics company whose mission is to identify robust markers of disease and develop them into ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results